Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
MUMBAI, June 18, 2015 /PRNewswire/ --
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 317 tables & figures over 279 pages. The personalized medicine (global & USA) market is presented as follows:
- By Company (e.g., Qiagen, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
- By Geography (US, UK, EU)
- By Segment (Targeted therapeutics, Companion Diagnostics)
- By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics)
- By Therapy (Cancer, Cardiovascular, Infectious Disease)
A wealth of financial data & business strategy information is provided including:
- Company financials, sales & revenue figures
- Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
- Business Model Strategies for Providers. Provider Systems and Academic Medical Centres
- Business Model Strategies for Payers & Governments
- Private and Public Funding and Personalized Medicine Reimbursement
- Revisions to Current Payment Systems and intellectual property
- How to Gain Market Penetration in the EU
- Cost-effectiveness and Business Value of Personalized Medicine
- Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
- Comprehensive account of company product portfolios & kits
SWOT, Economic & Regulatory Environment specifics include:
- Key strengths, weaknesses and threats influencing leading player position within the market
- Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
- Top fastest growing market segments and emerging opportunities
- Top pharmaceutical companies within the IPM by market share and revenue
- Comprehensive product portfolios, R&D activity and pipeline therapeutics
- M&A activity and future strategies of top personalized medicine pharmacos
- Personalized Medicine Regulation (USA, UK, Germany, France, Spain, Italy)
- CE-marked Personalized Medicine/Diagnostic Tests
- FDA Advances in Personalized Medicine Regulation
This report highlights a number of significant pharmacos and gives details of their operations, products, financials and business strategy.
- 23andMe
- Affymetrix
- Astex Pharmaceuticals
- Atossa Genetics
- CuraGen
- Celera Corporation (Quest Diagnostics)
- Celldex Therapeutics
- deCode Genetics (Amgen)
- Illumina
- Genelex
- Myriad
- Nodality
- Qiagen
Read more & request for sample page:
What you will gain:
- An in-depth understanding of the global personalized medicine market and it's environment
- Current market facts, figures and product lines of key players in the industry
- Emerging trends in key markets such as the US, UK, Germany and France
- Knowledge of how the personalized medicine market will integrate into the global healthcare market
- Technical insights into new generation sequencing technologies and ultra-high throughput sequencing
- Updates on bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies
- FDA approved pharmacogenetic tests and recognized biomarkers
- Information on key government and regulatory policies
- Strategies on how to adapt and restructure current business models to this industry
This report tackles key concerns to the personalized medicine market such as:
- Lack of regulatory policy and legislation in the US and Europe
- Reimbursement schemes and payers concerns
- Transition of investigational diagnostic assays and therapeutics to clinical practice
- Direct to consumer (DTC) test kits and implications for the public
Who should read this report?
- Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
- Industry professionals and business strategists will discover key information to propel their policies
- Investors will gain inside information to dominant players in the industry and future forecasts
- Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment
This report will tell you if the companies mentioned are:
- Strong, competitive players
- Pooling their resources for specific growth and therapeutic areas
- Investing strategically in R&D
- Have a history of strategic M&A activity
This detailed report is supported with 317 figures and tables over 279 pages and profiles the main pharmacos in personalized medicine.
Benefits of Investing in our Cutting-Edge Reports:
- Clients receive complementary content* with mid-level and enterprise wide licences
- Post-sale complementary consultation with senior expert analyst is included
- Use of tables and figures in your own reports and presentations is permitted
- Each report provides straight-talking strategic analysis & sector intelligence
- All reports are updated each quarter to give you the most up-to-date information
Table Of Contents
- Executive Summary
- Introduction and Background
- Personalized Medicine Therapeutics and Associated Companion Diagnostics
- Personalized Medicine and Integration into the Healthcare System
- Private and Public Funding and Personalized Medicine Reimbursement
- European Personalized Medicine Market - Payments and Investment
- Personalized Medicine -Business Model Analysis
- Personalized Medicine Main Industry Players
- Personalized Medicine Industry Products and Kits
- Personalized Medicine Market Analysis
- Strengths and Advantages of Personalized Medicine
- Restraints of the Personalized Medicine Market
- Personalized Medicine and Regulatory Policies
- Final Summary and Future Perspectives
Related Reports
- Personalized Medicine in Oncology Partnering Terms and Agreements
- Global Melanoma Therapeutics Industry 2015 Market Research Report
- Personalized Medicine Partnering Terms and Agreements
- Global Immunodiagnostics Industry 2015 Market Research Report
About Bharat Book Bureau
Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.
Contact Details:
Poonam
Bharat Book Bureau
India: +91-22-27810772, 27810773
Blog: https://www.bharatbook.com/blog/
W: https://www.bharatbook.com/
E: poonam@bharatbook.com
SOURCE Bharat Book Bureau
Share this article